Target intelligence / Profile preview

Histone protein (None)

Target
None
Molecular classification
Other, Chromatin structural protein, Nucleosome component
01

Overview

Histone proteins are a highly conserved family of basic nuclear proteins responsible for organizing eukaryotic DNA into structural units called nucleosomes. There are five major types—core histones (H2A, H2B, H3, and H4) form an octameric complex around which ~147 base pairs of DNA wrap to create the nucleosome core particle; linker histones such as the H1 family bind adjacent nucleosomes together into higher-order chromatin structures. Their N-terminal tails undergo extensive post-translational modifications—including methylation and acetylation—that regulate access to genetic information by controlling chromatin compaction state. These dynamic changes play critical roles in processes like transcriptional regulation, cell cycle progression/condensation during mitosis/meiosis/DNA repair/spermatogenesis. Aberrant modification patterns or mutations affecting these processes have been implicated in cancer development and other diseases involving genome instability.

Other names
HistonesCore histones (H2A, H2B, H3, and H4)Linker histones (H1 family)Chromatin proteins
02

Mechanism of action

Drugs do not target the core protein directly but modulate its function by altering post-translational modifications such as acetylation/methylation/phosphorylation to affect gene expression patterns.

03

Biological functions

DNA packaging/compactionStructural support of chromosomesRegulation of gene expression via chromatin structureEpigenetic regulation through post-translational modificationsDNA repair facilitationChromosome condensation during mitosis/meiosis
04

Disease associations

Cancer (via dysregulation of chromatin structure/modification)Neurodegenerative disease (implicated through epigenetic misregulation)Other diseases involving genome instability
05

Safety considerations

Targeting global chromatin regulators can lead to widespread changes in gene expression with potential toxicityoff-target effects due to the essential role of these proteins in all cells
06

Interacting drugs

Histone deacetylase inhibitors (e.g., vorinostat/SAHA)

2 more in the full profile.

07

Biomarkers

Specific post-translational modification patterns on certain residues of core histones can serve as biomarkers for cancer subtypes or treatment response ("histone marks")

Beyond the preview

Go deeper on Histone protein (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone protein (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call